As word has gotten around that macrocyclic gadolinium-based contrast agents (GBCAs) are more stable than linear GBCAs, and thus less likely to deposit in the brain, use of the former type has increased. However, in pediatric settings, at least, much education still needs to be directed to rads and referrers, according to the authors of a study published online March 10 in Pediatric Radiology.